Literature DB >> 18405062

Hyperserotonemia in autism: the potential role of 5HT-related gene variants.

Dubravka Hranilović1, Ruder Novak, Marina Babić, Mislav Novokmet, Zorana Bujas-Petković, Branimir Jernej.   

Abstract

Increased platelet serotonin level (PSL) has been consistently found in a portion of autistic patients. Suggested mechanisms for hyperserotonemia in autism have been increased synthesis of serotonin (5HT) by tryptophan hydroxylase (TPH), increased uptake into platelets through 5HT transporter (5HTt), diminished release from platelets through 5HT2A receptor (5HT2Ar) and decreased metabolism by monoamine oxydase (MAOA). The allelic influence of genes, encoding the mentioned 5HT elements, on PSL was investigated in 63 autistic subjects. Our study shows that 5HTt-LPR and -1438AG 5HT(2Ar) genotypes did not significantly affect PSL. However, significantly higher PSLs were observed in subjects with "cc" genotype of a218c TPH and subjects with "4" genotype of uVNTR MAOA. In addition, when TPH-cc and MAOA-4 were combined as "high 5HT" genotypes, a correlative increase in PSL was observed with the increase in the number of "high 5HT" genotypes. These results suggest a possible synergistic effect of genes regulating 5HT synthesis/degradation in dysregulation of the peripheral 5HT homeostasis of autistic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405062

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  14 in total

1.  Regulation of monoamine oxidase A by the SRY gene on the Y chromosome.

Authors:  Jason B Wu; Kevin Chen; Yunmin Li; Yun-Fai Chris Lau; Jean C Shih
Journal:  FASEB J       Date:  2009-08-06       Impact factor: 5.191

2.  MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.

Authors:  Flora Tassone; Lihong Qi; Wenting Zhang; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto
Journal:  Autism Res       Date:  2011-04-29       Impact factor: 5.216

Review 3.  Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Authors:  Holly R Robertson; Guoping Feng
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

4.  Hyperserotonemia in autism: activity of 5HT-associated platelet proteins.

Authors:  Dubravka Hranilović; Zorana Bujas-Petković; Maja Tomicić; Tatjana Bordukalo-Niksić; Sofia Blazević; Lipa Cicin-Sain
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

5.  Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia.

Authors:  Li-San Wang; Dubravka Hranilovic; Kai Wang; Ingrid E Lindquist; Lindsay Yurcaba; Zorana-Bujas Petkovic; Nicole Gidaya; Branimir Jernej; Hakon Hakonarson; Maja Bucan
Journal:  BMC Med Genet       Date:  2010-09-21       Impact factor: 2.103

6.  A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children.

Authors:  Gehan Ahmed Mostafa; Laila Yousef Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-06-22       Impact factor: 8.322

7.  Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism.

Authors:  Lina Ji; Ved Chauhan; Michael J Flory; Abha Chauhan
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  The serotonergic system: its role in pathogenesis and early developmental treatment of autism.

Authors:  D I Zafeiriou; A Ververi; E Vargiami
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

9.  Relationships among body mass, brain size, gut length, and blood tryptophan and serotonin in young wild-type mice.

Authors:  Ricardo Albay; Angela Chen; George M Anderson; Maggie Tatevosyan; Skirmantas Janusonis
Journal:  BMC Physiol       Date:  2009-03-25

10.  Origin of the blood hyperserotonemia of autism.

Authors:  Skirmantas Janusonis
Journal:  Theor Biol Med Model       Date:  2008-05-22       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.